Across TCGA pan-cancer cohorts, OR7E161P RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of OR7E161P’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where OR7E161P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E161P is over-expressed in tumor.
UCEC, HNSC, and BRCA are the cancer types where OR7E161P tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E161P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.